Page last updated: 2024-10-31

moclobemide and Somatoform Disorders

moclobemide has been researched along with Somatoform Disorders in 2 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pirildar, S1
Sezgin, U1
Elbi, H1
Uyar, M1
Zileli, B1
Rütten, J1

Trials

1 trial available for moclobemide and Somatoform Disorders

ArticleYear
A preliminary open-label study of moclobemide treatment of pain disorder.
    Psychopharmacology bulletin, 2003,Summer, Volume: 37, Issue:3

    Topics: Adult; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Moclobemide; Mon

2003

Other Studies

1 other study available for moclobemide and Somatoform Disorders

ArticleYear
[Moclobemide in treatment of somatoform depression. A case report].
    Fortschritte der Medizin, 1994, Mar-10, Volume: 112, Issue:7

    Topics: Activities of Daily Living; Aged; Benzamides; Depressive Disorder; Female; Humans; Moclobemide; Mono

1994